Pralidoxime
Pralidoxime is a published development and funding opportunity on Contexium. The donor or funder is Department of National Defence (DND). Project location(s): Canada. Applications close on 10 Nov 2026. NOTICE OF PROPOSED PROCUREMENT The Department of National Defence (DND) through the Strategic Medical Countermeasures Program on behalf of the Canadian Forces Health Services Group, has a requirement for Pralidoxime for the treatment of Canadian Armed Forces (CAF) members suspected of exposure to ch…
Opportunity overview
- Project name
- Pralidoxime
- Donor
- Department of National Defence (DND)
Key details
- Opportunity start date
- Opportunity end date
- Project location(s)
- Canada
Summary
Frequently asked questions
What is Pralidoxime?
Pralidoxime is a published development and funding opportunity on Contexium. The donor or funder is Department of National Defence (DND). Project location(s): Canada. Applications close on 10 Nov 2026. NOTICE OF PROPOSED PROCUREMENT The Department of National Defence (DND) through the Strategic Medical Countermeasures Program on behalf of the Canadian Forces Health Services Group, has a requirement for Pralidoxime for the treatment of Canadian Armed Forces (CAF) members suspected of exposure to ch…
Who is funding Pralidoxime?
Pralidoxime is funded by Department of National Defence (DND).
When is the deadline to apply for Pralidoxime?
The application deadline is 10 Nov 2026 19:00 (UTC).
Where will the Pralidoxime project take place?
The project location(s) are: Canada.
How can I apply for Pralidoxime?
Create a free Contexium account to view the full opportunity details and submit an application via the marketplace.